Insider · CIK 0001315224
Fisher David
Reports to the SEC for 8 companies · CHICAGO, IL
Transactions
50
Companies
8
Filings
6
CIK
0001315224
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-17 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-09-17 | ENVAEnova International, Inc.S Sale | −$3.7M |
| 2026-09-17 | ENVAEnova International, Inc.M Exercise/Conversion | +$430K |
| 2026-08-26 | ENVAEnova International, Inc.M Exercise/Conversion | +$188K |
| 2026-08-26 | ENVAEnova International, Inc.S Sale | −$2.17M |
| 2026-08-26 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-08-25 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-08-25 | ENVAEnova International, Inc.M Exercise/Conversion | +$197K |
| 2026-08-25 | ENVAEnova International, Inc.S Sale | −$2.32M |
| 2026-08-05 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARA Award | — |
| 2026-07-15 | ENVAEnova International, Inc.M Exercise/Conversion | +$238K |
| 2026-07-15 | ENVAEnova International, Inc.S Sale | −$2.66M |
| 2026-07-15 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-07-14 | ENVAEnova International, Inc.M Exercise/Conversion | +$353K |
| 2026-07-14 | ENVAEnova International, Inc.S Sale | −$3.94M |
| 2026-07-14 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-06-17 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-06-17 | ENVAEnova International, Inc.M Exercise/Conversion | +$685K |
| 2026-06-17 | ENVAEnova International, Inc.S Sale | −$6.58M |
| 2026-05-22 | ENVAEnova International, Inc.M Exercise/Conversion | +$63.8K |
| 2026-05-22 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-05-22 | ENVAEnova International, Inc.S Sale | −$487K |
| 2026-05-21 | ENVAEnova International, Inc.M Exercise/Conversion | +$149K |
| 2026-05-21 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-05-21 | ENVAEnova International, Inc.S Sale | −$1.15M |
| 2026-05-13 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARA Award | — |
| 2026-05-07 | ENVAEnova International, Inc.S Sale | −$3.46M |
| 2026-02-18 | ENVAEnova International, Inc.S Sale | −$1.07M |
| 2026-02-11 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARA Award | — |
| 2026-02-11 | ENVAEnova International, Inc.A Award | — |
| 2026-02-08 | ENVAEnova International, Inc.F Tax Payment | −$1.41M |
| 2026-02-08 | ENVAEnova International, Inc.F Tax Payment | −$1.35M |
| 2026-02-06 | ENVAEnova International, Inc.F Tax Payment | −$1.12M |
| 2026-02-05 | ENVAEnova International, Inc.F Tax Payment | −$646K |
| 2026-01-30 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-01-30 | ENVAEnova International, Inc.S Sale | −$6.28M |
| 2026-01-30 | ENVAEnova International, Inc.M Exercise/Conversion | +$910K |
| 2026-01-26 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2026-01-26 | ENVAEnova International, Inc.S Sale | −$1.51M |
| 2026-01-26 | ENVAEnova International, Inc.M Exercise/Conversion | +$229K |
| 2025-12-16 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2025-12-16 | ENVAEnova International, Inc.S Sale | −$2.4M |
| 2025-12-16 | ENVAEnova International, Inc.M Exercise/Conversion | +$359K |
| 2025-11-21 | ENVAEnova International, Inc.M Exercise/Conversion | +$144K |
| 2025-11-21 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
| 2025-11-21 | ENVAEnova International, Inc.S Sale | −$746K |
| 2025-11-06 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARA Award | — |
| 2025-10-27 | ENVAEnova International, Inc.M Exercise/Conversion | +$144K |
| 2025-10-27 | ENVAEnova International, Inc.S Sale | −$736K |
| 2025-10-27 | ENVAEnova International, Inc. · Non-Qualified Stock Option (right to buy) with limited SARM Exercise/Conversion | — |
Recent filings
- 4Fisher David0001193125-26-396711SEC(opens sec.gov)
- 4Fisher David0001193125-26-371385SEC(opens sec.gov)
- 4Fisher David0001315224-26-000004SEC(opens sec.gov)
- 4Fisher David0001315224-26-000002SEC(opens sec.gov)
- 4Fisher David0001193125-26-277580SEC(opens sec.gov)
- 4Fisher David0001193125-26-239437SEC(opens sec.gov)
Companies
Address
C/O ENOVA INTERNATIONAL, INC. 175 W. JACKSON BOULEVARD, SUITE 600
CHICAGO, IL, 60604